Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID

A Vojdani, E Vojdani, E Saidara, M Maes - Viruses, 2023 - mdpi.com
A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …

Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis

K Hashimoto - Molecular Psychiatry, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public …

Long COVID: clinical framing, biomarkers, and therapeutic approaches

V Conti, G Corbi, F Sabbatino, D De Pascale… - Journal of Personalized …, 2023 - mdpi.com
More than two years after the onset of the COVID-19 pandemic, healthcare providers are
facing an emergency within an emergency, the so-called long COVID or post-COVID-19 …

Long-Term effects of COVID-19: A review of current perspectives and mechanistic insights

C Lenz, MPE Slack, KM Shea, RR Reinert… - Critical Reviews in …, 2024 - Taylor & Francis
Abstract Although SARS-CoV-2, responsible for COVID-19, is primarily a respiratory
infection, a broad spectrum of cardiac, pulmonary, neurologic, and metabolic complications …

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence

M Buchynskyi, I Kamyshna, V Oksenych, N Zavidniuk… - Viruses, 2023 - mdpi.com
The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …

[HTML][HTML] Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine

L Ye, S Fan, P Zhao, C Wu, M Liu, S Hu, P Wang… - … Pharmaceutica Sinica B, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Effective treatments against …

Long COVID prevalence and impact on quality of life 2 years after acute COVID-19

Y Kim, S Bae, HH Chang, SW Kim - Scientific Reports, 2023 - nature.com
There has been an increasing interest in the long-term impact of long COVID. However, only
a few studies have investigated the clinical manifestations of long COVID 24 months after …

Dynamics of the microbiota and its relationship with post-COVID-19 syndrome

NC Moreno-Corona, O López-Ortega… - International Journal of …, 2023 - mdpi.com
Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple …

The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations

B Cao, X Wang, W Yin, Z Gao, B Xia - Mbio, 2024 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations are rapidly
emerging. In particular, beneficial mutations in the spike (S) protein, which can either make a …

Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome

M Brīvība, L Silamiķele, L Birzniece, L Ansone… - International Journal of …, 2024 - mdpi.com
The gut microbiome plays a pivotal role in the modulation of host responses during viral
infections, and recent studies have underscored its significance in the context of coronavirus …